EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Screen Time Among and Youth Children With Disabilities: A Systematic Review and Meta‐Analysis

Leigh M. Vanderloo, Matthew Bourke, Leah G. Taylor, Sophie M. Phillips, Aidan Loh, Katerina Disimino, Rebecca L. Bassett‐Gunter, Tyler Koo, Molly Thompson‐Hill, Patricia Tucker

Child: Care, Health and Development · 2025-07 · 51 (4)

DOI: 10.1111/cch.70136 ↗
AbstractBibliografische Angaben

Abstract

ABSTRACT Objective This paper aimed to review and synthesize screen time research among children and youth with disabilities. Methods Seven online databases were searched, and a machine learning–assisted systematic review model was used to identify relevant studies. English and French papers reporting on screen time among children and youth with a disability were eligible. Extracted data were synthesized by participant age, followed by type of screen time reporting. Meta‐analyses were conducted to estimate daily screen time and adherence to screen time guidelines using random effects meta‐analysis. Results Eighty‐one studies were included. Screen time ranged from 0.5 to 7.27 h/day and varied widely based on disability type. Pooled average screen time was 3.70, 3.28 and 3.39 h/day for children and youth with ASD, ADHD and CP, respectively. Conclusion Screen use is prominent among children and youth with disabilities. Limiting screen time in this group is critical in preventing numerous related consequences of excessive, prolonged use. Policy Implications Interventions targeting children and youth with disabilities are needed to decrease excessive screen time among this population and to inform future public health policy and setting‐specific practice.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →